Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05113368
Title Regorafenib Combined With Fulvestrant in Recurrent Low-Grade Serous Ovarian Cancer
Recruitment Recruiting
Gender female
Phase Phase II
Variant Requirements No
Sponsors Afshin Dowlati, MD
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA

Facility Status City State Zip Country Details
University Hospitals Cleveland Medical Center, Seidman Cancer Center, Case Comprehensive Cancer Center RECRUITING Cleveland Ohio 44106 United States Details
*Shaded cells indicate that there was no data available from clinicaltrials.gov for the field